ArticleFrontiers in sports and active living2026
Case Report: Unilateral resistance and impact loading during knee rehabilitation after grade-2 MCL injury was associated with hip-specific aBMD accrual in an elite female road cyclist.
Article in Frontiers in sports and active living, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Low areal bone mineral density (aBMD) is prevalent in elite road cyclists due to non-weight-bearing training loads and, at times, low energy availability (EA). Real-world, site-specific skeletal responses to targeted loading during rehabilitation remain insufficiently characterized. Case presentation: A 24-year-old WorldTour-level female road cyclist with low aBMD (Z-score ≤ -1.1) initiated a periodized resistance and impact loading program and daily vitamin D (800 IU). Three fasted-morning DXA and venous blood assessments (Oct-2024; Mar-2025; May-2025) were paired with training logs, dual-sided crank data, menstrual tracking, and weighed diet records. Five days after second DXA, a left grade-2 medial collateral ligament knee sprain precluded loading of the injured limb for ∼11 weeks; rehabilitation emphasized heavy unilateral resistance work of the contralateral limb while cycling volume was maintained. Results: From baseline to pre-injury, lumbar and bilateral femoral aBMD increased (all ≥least significant change, LSC). During unilateral rehabilitation, only the trained femur accrued further aBMD (total hip +2.8%; neck +3.8%; both ≥LSC), whereas the injured femur was stable/slightly lower (≤LSC). Whole-body BMD rose further; and leg-specific lean mass diverged (+uninjured/-injured). Right-leg pedal dominance (∼52%-54%) was similar in the 2024 and 2025 seasons, making cycling-related asymmetry an unlikely explanation for the March-May divergence. Across the three sampling time points, cortisol, 25-hydroxyvitamin D, thyroid hormones, and sex hormones were within reference ranges. Menstrual bleeding reappeared in late November 2024 but remained irregular; EA before baseline was frequently low, and after baseline it was assessed once and appeared higher, but no temporal trend can be inferred. Conclusion: Progressive resistance and impact loading were associated with rapid bilateral aBMD accrual pre-injury, and unilateral high-strain loading during knee rehabilitation after a grade-2 MCL sprain coincided with site-specific increases in femoral aBMD despite preserved cycling volume. These findings highlight rehabilitation periods as practical windows to deliver targeted bone-loading in non-weight-bearing endurance athletes and support the feasibility of brief, targeted bone-loading as an in-season maintenance strategy, while contributions from energetic and reproductive factors cannot be excluded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.